Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram

Results The therapeutic response evaluated in Hamilton Scale for Depression(HAM-D), Montgomery and Äsberg Depression Rating Scale (M.A.D.R.S. ), Mini Mental State Examination (M.M.S.E.) and Global Clinical Impression (G.C.I.) scores during 8 months. In the third group who received the two drugs associated, had much better response than the others and “brain enhancer”. Conclusions The group who received the combination of the nootropic agent Galantamine with antidepressant (SSRIs) Escitalopram had a relevant satisfactory therapeutic response (the best result), so there is a possible relation between the deficit in cholinergic systems and depression. Could be cerebral cholinergic systems deficit a generator of Depressive Disorder? Attention and memory functions are closely tied to the cholinergic neurotransmitter system. The cholinergic system is one of the neurotransmitter systems implicated in the pathophysiology of mood disorders. Evidence suggests that during major depressive episodes, the cholinergic system is hypersensitive to acetylcholine.